GiveWell is launching a new RFI to expand and strengthen our malaria grantmaking in Africa and help our donors make a greater impact. Expressions of interest can be submitted through one of two tracks, the first for malaria chemoprevention and vector control pilot programs and the second for research and evaluation. Submissions are due June 24.
Learn More
Most of GiveWell’s grantmaking focuses on programs that reduce child mortality, but our growing research capacity has expanded what we’re able to evaluate and fund, including highly cost-effective programs that meaningfully improve quality of life. In a recent podcast episode, GiveWell CEO and co-founder Elie Hassenfeld speaks with Program Officer Meika Ball about our grant to MiracleFeet—an organization that expands access to clubfoot treatment—and her recent site visit to see the program in action in Côte d’Ivoire.
Listen Here: Evaluating and Funding a New Kind of Grant
Save the date for our upcoming webinar, Looking Back to Give Better: How GiveWell Evaluates Its Grantmaking, on Tuesday, June 9. GiveWell co-founder and CEO Elie Hassenfeld will moderate a conversation with Program Directors Alex Cohen and Julie Faller about how we evaluate whether a grant achieved the impact we initially estimated—and how we use those findings to make better impact estimates over time.
Register Here
Vitamin A supplementation has one of the strongest evidence bases of any program we’ve evaluated. But when you dig in, the evidence is more complicated than it looks. GiveWell Senior Researcher Stephan Guyenet joins CEO and co-founder Elie Hassenfeld on the GiveWell Conversations podcast to talk about the evidence for vitamin A supplementation, the hard questions that remain, and how our expanded research capacity is helping us go deeper so we can direct funding more effectively.
Listen Here: Scrutinizing One of Our Longest-Funded Programs
GiveWell Updates
Learn MoreGiveWell is launching a new RFI to expand and strengthen our malaria grantmaking in Africa and help our donors make a greater impact. Expressions of interest can be submitted through one of two tracks, the first for malaria chemoprevention and vector control pilot programs and the second for research and evaluation. Submissions are due June 24.
Listen Here: Evaluating and Funding a New Kind of GrantMost of GiveWell’s grantmaking focuses on programs that reduce child mortality, but our growing research capacity has expanded what we’re able to evaluate and fund, including highly cost-effective programs that meaningfully improve quality of life. In a recent podcast episode, GiveWell CEO and co-founder Elie Hassenfeld speaks with Program Officer Meika Ball about our grant to MiracleFeet—an organization that expands access to clubfoot treatment—and her recent site visit to see the program in action in Côte d’Ivoire.
Register HereSave the date for our upcoming webinar, Looking Back to Give Better: How GiveWell Evaluates Its Grantmaking, on Tuesday, June 9. GiveWell co-founder and CEO Elie Hassenfeld will moderate a conversation with Program Directors Alex Cohen and Julie Faller about how we evaluate whether a grant achieved the impact we initially estimated—and how we use those findings to make better impact estimates over time.
Listen Here: Scrutinizing One of Our Longest-Funded ProgramsVitamin A supplementation has one of the strongest evidence bases of any program we’ve evaluated. But when you dig in, the evidence is more complicated than it looks. GiveWell Senior Researcher Stephan Guyenet joins CEO and co-founder Elie Hassenfeld on the GiveWell Conversations podcast to talk about the evidence for vitamin A supplementation, the hard questions that remain, and how our expanded research capacity is helping us go deeper so we can direct funding more effectively.